Penny Stock to Buy #3 – Pluristem Therapeutics (PSTI)
Pluristem Therapeutics (NASDAQ: PSTI) is a biotherapeutics company that commercializes treatments for several severe degenerative, ischemic and autoimmune disorders. Based in Israel, Pluristem develops its products from adult stromal cell sources, rather than stem cells.
In the last 12 months, PSTI stock has gained an impressive 148%, compared to a gain of 19% for the Nasdaq itself. This penny stock is also up nearly 31% since the middle of March. Trading near $2.93 currently, PSTI stock has nearly tripled its 52-week low of 98 cents.